← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
The Cleveland Clinic Foundation
$109,280,799
Total funding
118
Grants
Funding over time
peak $12.7M · FY2008–25$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$108,001,822 · 115
DOE$924,858 · 1
NASA$354,119 · 2
By mechanism
—$109,280,799 · 118
Investigators at The Cleveland Clinic Foundation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
CLINICAL STUDY OF VASCULAR PLAQUE DETERMINATION FOR STROKE RISK ASSESSMENT$4,333,094
· FY2020 · Defense Health Agency
REFERENCE MODELS FOR MULTI-LAYER TISSUE STRUCTURES$3,588,196
· FY2015 · Department of the Army
TROOP READINESS EVALUATION WITH AN AUGMENTED REALITY RETURN-TO-DUTY (READY) SYSTEM: AN OBJECTIVE METHOD OF EVALUATING SERVICE MEMBER PERFORMANCE FOLLOWING MTBI$3,491,232
· FY2024 · Defense Health Agency
PRIMARY IMMUNOPREVENTION OF TRIPLE-NEGATIVE BREAST CANCER$3,469,360
· FY2017 · Defense Health Agency
IMPROVING SPINAL CORD INJURY REHABILITATION INTERVENTIONS BY RETRAINING THE BRAIN$3,153,167
· FY2018 · Defense Health Agency
A GUT-RESTRICTED SMALL MOLECULE THERAPEUTIC FOR A NOVEL TARGET TO TREAT INFLAMMATORY BOWEL DISEASE$3,140,000
· FY2022 · Defense Health Agency
PRIMARY IMMUNOPREVENTION OF TRIPLE-NEGATIVE BREAST CANCER$2,755,184
· FY2017 · Defense Health Agency
NEXT GENERATION DNMT1 DEPLETION THERAPY FOR LEUKEMIA$2,617,431
· FY2009 · Department of Defense
ROLE OF STRESS IN THE DEGRADATION OF INTESTINAL IGA AND INTESTINAL HEALTH$2,602,024
· FY2024 · Defense Health Agency
A PHASE I ASSESSMENT OF MESENCHYMAL STEM CELLS FOR THE TREATMENT OF MULTIPLE SCLEROSIS$2,418,169
· FY2010 · Department of the Army
TROOP READINESS EVALUATION WITH AUGMENTED REALITY RETURN-TO-DUTY (READY) SYSTEM.$1,999,790
· FY2019 · Defense Health Agency
DEVELOPING NEUPRON FOR ACUTE SPINAL CORD INJURY: IDENTIFYING SURROGATE BIOMARKERS FOR TREATMENT EFFICACY$1,917,278
· FY2025 · Defense Health Agency
STRENGTHENING THE ANTIMICROBIAL ARSENAL OF THE INTESTINAL EPITHELIUM TO COUNTERACT MULTIDRUG-RESISTANT ENTERIC PATHOGENS$1,878,300
· FY2019 · Department of the Army
TARGETING THE INNATE IMMUNE RESPONSE TO COMBAT ANTIBIOTIC-RESISTANT BACTERIAL INFECTIONS$1,875,450
· FY2016 · Department of the Army
VASCULAR PLAQUE DETERMINATION FOR STROKE RISK ASSESSMENT$1,756,026
· FY2016 · Department of the Army
DEVELOPING PRO-NP FOR ACUTE SPINAL CORD INJURY$1,723,656
· FY2016 · Department of the Army
PORTABLE BIOCHIP FOR RAPID DETECTION OF BIOWARFARE AGENTS$1,628,294
· FY2008 · Department of Defense
"NOVEL GENETIC MODELS TO STUDY THE ROLE OF INFLAMMATION IN BRAIN INJURY-INDUCED ALZHEIEMER'S PATHOLGY"$1,545,000
· FY2012 · Department of Defense
AN INNOVATIVE REPAIR STRATEGY TO TARGET INHIBITORY GLIA SCARS AFTER SPINAL CORD INJURY$1,520,750
· FY2019 · Defense Health Agency
THE QUANTIFICATION OF VISUAL FUNCTION AND POSTURAL STABILITY UNDER SINGLE AND DUAL TASK CONDITIONS USING MOBILE TECHNOLOGY$1,499,987
· FY2016 · Department of the Army